Particle.news
Sales Forecasting Earnings Reports Cancer Treatment Share Prices Tariffs Artificial Intelligence Revenue Growth Sales Performance Consumer Behavior Tariffs
The luxury retailer reported a 2% sales decline and a 12% drop in EBIT but outperformed analyst forecasts, reaffirming its cautious 2025 outlook.
